Frances E Jensen

Title: Frances E. Jensen: Pioneering Innovations in Neurology

Introduction

Frances E. Jensen is a distinguished inventor and researcher based in Chestnut Hill, MA (US). She has made significant contributions to the field of neurology, particularly in the development of innovative treatments for neurological disorders. With a total of 4 patents to her name, Jensen's work has the potential to impact the lives of many individuals suffering from epilepsy and other related conditions.

Latest Patents

One of Jensen's latest patents focuses on Transcranial Magnetic Stimulation (TMS) methods and apparatus. This patent provides methods and devices designed for treating subjects with TMS, particularly for the treatment of ongoing seizures. Additionally, her work explores the use of TMS as an antiepileptogenic and for determining the preferential placement of intracranial probes. Another notable patent involves combination therapies that utilize inhibitors of GABA transaminase and NKCC1. This innovative approach suggests that coadministering inhibitors of NKCC1, such as bumetanide, with inhibitors of GABA transaminase, like vigabatrin, can reduce retinal toxicity and intramyelinic edema.

Career Highlights

Throughout her career, Frances E. Jensen has worked with prominent institutions, including Children's Medical Center Corporation and Beth Israel Deaconess Medical Center, Inc. Her research has garnered attention for its potential to revolutionize treatment methodologies in neurology.

Collaborations

Jensen has collaborated with esteemed colleagues such as Joseph Volpe and Paul A. Rosenberg, contributing to a rich exchange of ideas and advancements in her field.

Conclusion

Frances E. Jensen's innovative work in neurology, particularly her patents related to TMS and combination therapies, showcases her commitment to improving treatment options for neurological disorders. Her contributions continue to pave the way for future advancements in medical science.